MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Bioscience Regional Clusters & HotSpots
*Industry: Maryland (Medical & Health Information Technology, Biomedical, Biopharmaceutical & Biotechnology Sectors)
Delfi Diagnostics
Organization & Developments: Delfi Diagnostics
Parents
Delfi Diagnostics
Children
2022: It is also working with other research institutions to develop new applications, including screening for other cancer types, multi-cancer early detection, and treatment monitoring.
2022: The company is currently validating the technology for early detection of lung and other cancers in a 15,000-person prospective trial called CASCADE-LUNG.
Delfi has harnessed a proprietary whole-genome low-depth sequencing approach for analysis of cell-free DNA fragmentation initially developed at Johns Hopkins.
Delfi’s technology uses an approach called cell-free DNA fragmentation, or “fragmentomics,” which is related to the way DNA interacts with nucleosomes and is organized in the chromosomes.
Jumps
Finance & Acquisitions: Delfi Diagnostics
Key People: Delfi Diagnostics